Causaly AI finds hidden evidence in the world’s biomedical literature. Our mission is to transform how humans can find, visualise and interpret biomedical knowledge, and contribute to accelerating solutions to some of the greatest challenges we face. Our platform understands evidence by semantics and temporal occurrence, and machine-reads all published evidence to date, identifying all known cause and effect relationships, rapidly accelerating life science research and discovery. Current applications include drug discovery, toxicology, safety, epidemiology, due diligence, drug commercialisation, market access, clinical care and more.
Causaly is an AI for Biomedical Cause & Effect discovery, empowering researchers and decision makers to quickly find causal evidence and generate insights from vast amounts of documents. The company is developing a machine-reading platform that turns free-flow text into causal knowledge graphs and applies machine learning to surface new knowledge. This helps users to accelerate their research schedules and improve time-to-insight significantly.
Total Funding: $6,000,000
Funding Stage: Series A
Business Stage: Scaling Up
Market: B2B
Company Size: 26 to 50
Founded: 2017
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at Causaly
Software Engineer, Javascript
Athens, Athens
Science Liaison (Biomedicine)
Athens, Athens
Data Quality Analyst
Athens, Athens
Product Owner
Athens, Athens
Financial Controller/ Administator
Athens, Athens